This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Functional Reach Test
Timeframe: Baseline, Immediately Post-Treatment (an average of 3 months)
Change in Timed Up and Go test
Timeframe: Baseline, Immediately Post-Treatment (an average of 3 months)
Change in 30 second chair stand test
Timeframe: Baseline, Immediately Post-Treatment (an average of 3 months)